By overexpressing TAGLN2 in CAR T-cells to circumvent stress responses and maintain CAR T-cell fitness, they demonstrated that TAGLN2-armored CAR T-cells improved control of metastatic disease progression and survival of mouse models of ovarian cancer (142). This evidence concerns the gene TAGLN2 and ovarian carcinoma.